Genetic testing plays a significant role in identifying individuals at high risk for ovarian cancer. Mutations in genes such as BRCA1 and BRCA2 significantly increase the risk. Knowing one's genetic status can inform decisions about preventive measures, including risk-reducing surgery and increased surveillance.
